Ranolazine, a new treatment for chronic, stable angina, is discussed as a safe and effective option for patients in a New Drug Class paper released on October 10, 2008 in The Lancet. Chronic stable angina is a prolonged chest pain which is often linked to heart disease. It is often present when the patient is exercising.
E-Mail this Story
Ranolazine, a new treatment for chronic, stable angina, is discussed as a safe and effective option for patients in a New Drug Class paper released on October 10, 2008 in The Lancet. Chronic stable angina is a prolonged chest pain which is often linked to heart disease. It is often present when the patient is exercising.
